share_log

HC Wainwright & Co. Maintains Buy on Pyxis Oncology, Raises Price Target to $7

HC Wainwright & Co. Maintains Buy on Pyxis Oncology, Raises Price Target to $7

HC Wainwright & Co.维持对Pyxis Oncology的买入,将目标股价上调至7美元
Moomoo 24/7 ·  03/22 06:16

HC Wainwright & Co. analyst Swayampakula Ramakanth maintains Pyxis Oncology (NASDAQ:PYXS) with a Buy and raises the price target from $4 to $7.

HC Wainwright & Co. 分析师Swayampakula Ramakanth维持Pyxis Oncology(纳斯达克股票代码:PYXS)的买入并将目标股价从4美元上调至7美元。

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发